Digital and Analogical Cognitive Stimulation in Older Adults with Alzheimer’s Disease: A Multicenter Randomized Controlled Trial Study Protocol
DOI:
https://doi.org/10.20344/amp.24360Keywords:
Aged, Alzheimer Disease, Cognitive Dysfunction, Dementia, Food-related quality of life, Randomized Controlled TrialAbstract
The growing incidence of neurodegenerative diseases in older adults, with the prevalence of Alzheimer’s disease, progressively affects their quality of life. Cognitive stimulation is a psychosocial intervention that has shown consistent benefits in the lives of people with dementia from mild to moderate stages. The present study aims to evaluate the effectiveness of digital and analogical cognitive stimulation, when compared with usual care, on overall cognitive function, emotional state, and quality of life. It also aims to investigate whether institutional and territorial characteristics of social care services moderate these effects. This is a three-arm multicenter randomized controlled trial with repeated measures (pre-intervention, post-intervention, and follow-up). The intervention consists of 24 individually applied (digital and analogical) cognitive stimulation sessions, twice a week, for 12 weeks, in two intervention groups. The control group receives usual care. The study follows the recommendations of the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2025), including the extension for non-pharmacological interventions. The sample size is estimated at 222 older adults with a probable diagnosis of mild to moderate Alzheimer’s disease. Sociodemographic, social, health and clinical data, as well as information on care provider institutions, will be collected and analyzed. Outcomes include cognition (global cognition, memory, and executive function), emotional state (anxiety and depression), and quality of life. All outcomes will be assessed at baseline, endpoint, and follow-up, with comparisons between the intervention groups and the control group.
Downloads
References
World Health Organization. Dementia. 2021. [cited 2025 Nov 05]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
Woods B, Rai HK, Elliott E, Aguirre E, Orrell M, Spector A. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2023;CD005562. DOI: https://doi.org/10.1002/14651858.CD005562.pub3
Clare L, Woods RT. Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer’s disease: a review. Neuropsychol Rehabil. 2004;14:385–401. DOI: https://doi.org/10.1080/09602010443000074
Huntley JD, Gould RL, Liu K, Smith M, Howard RJ. Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression. BMJ Open. 2015;5:e005247. DOI: https://doi.org/10.1136/bmjopen-2014-005247
McDermott O, Charlesworth G, Hogervorst E, Stoner C, Moniz-Cook E, Spector A, et al. Psychosocial interventions for people with dementia: a synthesis of systematic reviews. Aging Ment Health. 2019;23:393–403. DOI: https://doi.org/10.1080/13607863.2017.1423031
Woods B, O’Philbin L, Farrell EM, Spector AE, Orrell M. Reminiscence therapy for dementia. Cochrane Database Syst Rev. 2018;CD001120. DOI: https://doi.org/10.1002/14651858.CD001120.pub3
National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. 2018. [cited 2025 Nov 05]. Available from: https://www.nice.org.uk/guidance/ng97/resources/.
Justo-Henriques S, Marques-Castro A, Otero P, Vázquez F, Torres Á. Long-term individual cognitive stimulation program in patients with mild neurocognitive disorder: a pilot study. Rev Neurol. 2019;68:281-9. DOI: https://doi.org/10.33588/rn.6807.2018321
Justo-Henriques SI, Otero P, Torres AJ, Vázquez FL. Effect of long-term individual cognitive stimulation program for people with mild neurocognitive disorder. Rev Neurol. 2021;73:121-9. DOI: https://doi.org/10.33588/rn.7304.2021114
Justo-Henriques SI, Pérez-Sáez E, Marques-Castro AE, Carvalho JO. Effectiveness of a year-long individual cognitive stimulation program in Portuguese older adults with cognitive impairment. Aging Neuropsychol Cogn. 2023;30:321-35. DOI: https://doi.org/10.1080/13825585.2021.2023458
Justo-Henriques SI, Pérez-Sáez E, Carvalho JO, Lemos R, Ribeiro O. Effects of an individual cognitive stimulation intervention on global cognition, memory, and executive function in older adults with mild to moderate Alzheimer’s disease. Clin Neuropsychol. 2025;39:1506-24. DOI: https://doi.org/10.1080/13854046.2024.2416568
Georgopoulou EN, Nousia A, Siokas V, Martzoukou M, Zoupa E, Messinis L, et al. Computer-based cognitive training vs. paper-and-pencil training for language and cognitive deficits in Greek patients with mild Alzheimer’s disease: a preliminary study. Healthcare. 2023;11:443. DOI: https://doi.org/10.3390/healthcare11030443
Memórias de Norte a Sul. Mealhada: Replicar Socialform; 2022.
Domínios Cognitivos. Mealhada: Replicar Socialform; 2025.
Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 statement: updated guideline for protocols of randomised trials. BMJ. 2025;389:e081477. DOI: https://doi.org/10.1136/bmj-2024-081477
Hróbjartsson A, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ. 2025;389:e081660. DOI: https://doi.org/10.1136/bmj-2024-081660
R Core Team. R: a language and environment for statistical computing. Vienna: The R Foundation for Statistical Computing; 2025.
Lüdecke D. sjstats: statistical functions for regression models (Version 0.19.0) [R package]. [cited 2025 Jun 15]. Available from: https://cran.r-project.org/web/packages/sjstats/index.html.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed.. Washington D.C.: APA; 2022. DOI: https://doi.org/10.1176/appi.books.9780890425787
Folstein F, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98. DOI: https://doi.org/10.1016/0022-3956(75)90026-6
Guerreiro M, Silva AP, Botelho MA, Leitão O, Castro-Caldas A, Garcia C. Adaptação à população portuguesa da tradução do “Mini Mental State Examination” (MMSE) Rev Port Neurol. 1994;1:9-10.
Mohs RC, Rosen WG, Davis KL. The Alzheimer’s disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull. 1983;19:448-50.
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356-64. DOI: https://doi.org/10.1176/ajp.141.11.1356
Guerreiro M, Fonseca S, Barreto J, Garcia C. Escala de avaliação da doença de Alzheimer (Alzheimer Disease Assessment Scale [ADAS]). In: Mendonça A, Guerreiro M, Grupo de Estudos de Envelhecimento Cerebral e Demência, editors. Escalas e testes na demência. Porto Salvo: Novartis, 2008.
Rami LM, Sanchez-Valle R, Bosch B, Villar BA. Screening for amnestic mild cognitive impairment and early Alzheimer’s disease with Memory Alteration Test in the primary care population. Int J Geriatr Psychiatry. 2007;22:294-304. DOI: https://doi.org/10.1002/gps.1672
Sousa M, Pereira A, Costa R, Rami L. Initial phase of adaptation of Memory Alteration Test (MAT) in a Portuguese sample. Arch Gerontol Geriatr. 2015;61:103-8. DOI: https://doi.org/10.1016/j.archger.2015.03.008
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurol. 2000;55:1621-6. DOI: https://doi.org/10.1212/WNL.55.11.1621
Lima CF, Meireles LP, Fonseca R, Castro SL, Garrett C. The frontal assessment battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. J Neurol. 2008;255:1756-61. DOI: https://doi.org/10.1007/s00415-008-0024-6
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17:37-49. DOI: https://doi.org/10.1016/0022-3956(82)90033-4
Apóstolo JL, Loureiro LM, Carvalho IA, Alves I, Batista DF, Sfetcu R. Contribuição para a adaptação da Geriatric Depression Scale -15 para a língua portuguesa Rev Enfer Refer. 2014;3:65-73. DOI: https://doi.org/10.12707/RIV14033
Pachana NA, Byrne GJ, Siddle H, Koloski N, Harley E, Arnold E. Development and validation of the Geriatric Anxiety inventory. Int Psychogeriatr. 2007;19:103–14. DOI: https://doi.org/10.1017/S1041610206003504
Ribeiro O, Paúl C, Simões MR, Firmino H. Portuguese version of the Geriatric Anxiety inventory: transcultural adaptation and psychometric validation. Aging Ment Health. 2011;15:742-8. DOI: https://doi.org/10.1080/13607863.2011.562177
Logsdon RG, Gibbons LE, McCurry SM, Teri L. Quality of life in Alzheimer’s disease: patient and caregiver reports. J Ment Health Aging. 1999;5:21–32. DOI: https://doi.org/10.1037/t03352-000
Bárrios H, Verdelho A, Narciso S, Gonçalves-Pereira M, Logsdon R, de Mendonça A. Quality of life in patients with cognitive impairment: validation of the quality of life–Alzheimer’s disease scale in Portugal. Int Psychogeriatr. 2013;25:1085-96. DOI: https://doi.org/10.1017/S1041610213000379
Justo-Henriques SI. Individual intervention protocol based on cognitive stimulation therapy for older adults with mild neurocognitive disorder. Rev Enfer Refer. 2021;5:e20100.
Sarpourian F, Bahaadinbeigy K, Fatemi Aghda SA, Fatehi F, Ebrahimi S, Fallahnezhad M. Effectiveness of computer-based telerehabilitation software (RehaCom) compared to other treatments for patients with cognitive impairments: a systematic review. Digit Health. 2024;10. DOI: https://doi.org/10.1177/20552076241290957
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
